Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point

Gut. 2024 Mar 7;73(4):708-709. doi: 10.1136/gutjnl-2023-329712.
No abstract available

Keywords: HELICOBACTER PYLORI - TREATMENT.

Publication types

  • Letter

MeSH terms

  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Clarithromycin / therapeutic use
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Helicobacter Infections* / drug therapy
  • Helicobacter pylori*
  • Humans
  • Metronidazole / therapeutic use
  • Proton Pump Inhibitors / therapeutic use

Substances

  • Clarithromycin
  • Anti-Bacterial Agents
  • Amoxicillin
  • Proton Pump Inhibitors
  • Metronidazole